Skip to main content

Table 3 Univariate & multivariate logistic regression for UKLFU vs. CCAs - NOT on HAART (n = 532)

From: High rate of loss to clinical follow up among African HIV-infected patients attending a London clinic: a retrospective analysis of a clinical cohort

 

n (%)*

Univariate OR (95% CI )

P value

Multivariate OR (95% CI)

P value

Age at HIV clinic registration (per year older)

n = 532

0.99 (0.97-1.01)

0.308

-

-

Gender-ethnicity risk group

n = 515

    

   White MSM

106 (20.6

1.00 (REF)

 

1.00 (REF)

 

   Black African/Caribbean MSM

25 (4.9%)

0.61 (0.23-1.67)

0.340

0.58 (0.17-1.94)

0.373

   Black African heterosexual female

158 (30.7%)

1.67 (1.00-2.78)

0.048

1.57 (0.82-2.98)

0.172

   Black African heterosexual male

66 (12.8%)

4.17 (2.17-8.03)

< 0.001

3.91 (1.77-8.64)

0.001

   Black Caribbean heterosexual female

30 (5.8%)

1.13 (0.48-2.62)

0.783

1.47 (0.55-3.90)

0.442

   Black Caribbean heterosexual male

20 (3.9%)

2.38 (0.90-6.26)

0.080

2.16 (0.67-7.01)

0.199

   White heterosexual female

16 (3.1%)

0.88 (0.29-2.74)

0.831

0.46 (0.09-2.38)

0.356

   White heterosexual male

12 (2.3%)

0.65 (0.17-2.54)

0.534

1.91 (0.36-10.12)

0.448

   Other

82 (15.9%)

1.68 (0.93-3.03)

0.086

1.48 (0.69-3.20)

0.318

Year of KCH HIV clinic registration

n = 532

0.78 (0.74-0.84)

< 0.001

0.75 (0.68-0.83)

< 0.001

   2003-2005

255

1.00 (REF)

 

1.00 (REF)

 

   2000-2002

191

2.77 (1.88-4.09)

< 0.001

2.91 (1.77-4.78)

< 0.001

   1997-1999

86

4.70 (2.78-7.94)

< 0.001

5.26 (2.71-10.19)

< 0.001

CDC stage prior to LFU Ç‚

n = 495

    

   AIDS

31 (6.3%)

1.00 (REF)

 

1.00 (REF)

 

   Symptomatic

131 (26.5%)

0.40 (0.18-0.89)

0.025

0.83 (0.28-2.44)

0.732

   Asymptomatic

333 (67.3%)

0.64 (0.30-1.33)

0.229

1.51 (0.52-4.41)

0.446

CD4 cell count prior to LFU Ç‚ , cells/mm 3

n = 456

    

   > 350

306 (67.1%)

1.00 (REF)

 

1.00 (REF)

 

   200-350

103 (22.6%)

1.03 (0.65-1.64)

0.908

0.98 (0.58-2.44)

0.941

   < 200

47 (10.3%)

3.55 (1.86-6.79)

< 0.001

3.24 (1.49-7.04)

0.003

  1. * N values are for the number of patients included in univariate analysis. Ç‚ or prior to 31st December 2006 for CCAs